Crane Alan L
Insider CIK 1294361 · CERU Director, 10% owner · TTOO Director · PAND Director, 10% owner
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| PAND Pandion Therapeutics, Inc. | D To issuer deriv | 2021-04-01 | 2021-04-01 | 13,997 | — | $0 | 0 | SEC↗ |
| PAND Pandion Therapeutics, Inc. | U Tender | 2021-04-01 | 2021-04-01 | 3,090,801 | $60.00 | $185.45M | 0 | SEC↗ |
| PAND Pandion Therapeutics, Inc. | U Tender | 2021-04-01 | 2021-04-01 | 84,158 | $60.00 | $5.05M | 0 | SEC↗ |
| PAND Pandion Therapeutics, Inc. | U Tender | 2021-04-01 | 2021-04-01 | 110,621 | $60.00 | $6.64M | 0 | SEC↗ |
| PAND Pandion Therapeutics, Inc. | U Tender | 2021-04-01 | 2021-04-01 | 336,314 | $60.00 | $20.18M | 0 | SEC↗ |
| PAND Pandion Therapeutics, Inc. | C Conversion deriv | 2020-07-21 | 2020-07-21 | 49,652 | — | $0 | 0 | SEC↗ |
| PAND Pandion Therapeutics, Inc. | C Conversion deriv | 2020-07-21 | 2020-07-21 | 14,196,152 | — | $0 | 0 | SEC↗ |
| PAND Pandion Therapeutics, Inc. | C Conversion deriv | 2020-07-21 | 2020-07-21 | 508,090 | — | $0 | 0 | SEC↗ |
| PAND Pandion Therapeutics, Inc. | C Conversion deriv | 2020-07-21 | 2020-07-21 | 1,387,268 | — | $0 | 0 | SEC↗ |
| PAND Pandion Therapeutics, Inc. | C Conversion deriv | 2020-07-21 | 2020-07-21 | 107,768 | — | $0 | 0 | SEC↗ |
| PAND Pandion Therapeutics, Inc. | C Conversion | 2020-07-21 | 2020-07-21 | 9,736 | — | $0 | 109,373 | SEC↗ |
| PAND Pandion Therapeutics, Inc. | P Buy | 2020-07-21 | 2020-07-21 | 1,248 | $18.00 | $22.5K | 110,621 | SEC↗ |
| PAND Pandion Therapeutics, Inc. | P Buy | 2020-07-21 | 2020-07-21 | 34,863 | $18.00 | $627.5K | 3,090,801 | SEC↗ |
| PAND Pandion Therapeutics, Inc. | C Conversion | 2020-07-21 | 2020-07-21 | 21,133 | — | $0 | 70,158 | SEC↗ |
| PAND Pandion Therapeutics, Inc. | P Buy | 2020-07-21 | 2020-07-21 | 14,000 | $18.00 | $252.0K | 84,158 | SEC↗ |
| PAND Pandion Therapeutics, Inc. | C Conversion | 2020-07-21 | 2020-07-21 | 99,637 | — | $0 | 99,637 | SEC↗ |
| PAND Pandion Therapeutics, Inc. | C Conversion | 2020-07-21 | 2020-07-21 | 272,046 | — | $0 | 3,055,938 | SEC↗ |
| PAND Pandion Therapeutics, Inc. | C Conversion | 2020-07-21 | 2020-07-21 | 2,783,892 | — | $0 | 2,783,892 | SEC↗ |
| PAND Pandion Therapeutics, Inc. | A Award deriv | 2020-07-17 | 2020-07-21 | 13,997 | — | $0 | 13,997 | SEC↗ |
| CERU Cerulean Pharma Inc. | A Award deriv | 2016-06-22 | 2016-06-24 | 20,000 | — | $0 | 20,000 | SEC↗ |
| CERU Cerulean Pharma Inc. | A Award deriv | 2015-06-26 | 2015-06-30 | 11,000 | — | $0 | 11,000 | SEC↗ |
| CERU Cerulean Pharma Inc. | A Award deriv | 2014-09-16 | 2014-09-16 | 16,000 | — | $0 | 16,000 | SEC↗ |
| CERU Cerulean Pharma Inc. | D To issuer deriv | 2014-09-16 | 2014-09-16 | 35,765 | — | $0 | 0 | SEC↗ |
| TTOO T2 Biosystems, Inc. | P Buy | 2014-08-12 | 2014-08-14 | 30,000 | $11.00 | $330.0K | 30,000 | SEC↗ |
| CERU Cerulean Pharma Inc. | C Conversion deriv | 2014-04-15 | 2014-04-15 | 30,432 | — | $0 | 0 | SEC↗ |
| CERU Cerulean Pharma Inc. | C Conversion deriv | 2014-04-15 | 2014-04-15 | 8,598,139 | — | $0 | 0 | SEC↗ |
| CERU Cerulean Pharma Inc. | C Conversion deriv | 2014-04-15 | 2014-04-15 | 9,509,913 | — | $0 | 0 | SEC↗ |
| CERU Cerulean Pharma Inc. | C Conversion deriv | 2014-04-15 | 2014-04-15 | 2,513,500 | — | $0 | 0 | SEC↗ |
| CERU Cerulean Pharma Inc. | C Conversion deriv | 2014-04-15 | 2014-04-15 | 1,631,107 | — | $0 | 0 | SEC↗ |
| CERU Cerulean Pharma Inc. | C Conversion deriv | 2014-04-15 | 2014-04-15 | 3,846,154 | — | $0 | 0 | SEC↗ |
| CERU Cerulean Pharma Inc. | J Other deriv | 2014-04-15 | 2014-04-15 | 0 | — | $0 | 0 | SEC↗ |
| CERU Cerulean Pharma Inc. | J Other deriv | 2014-04-15 | 2014-04-15 | 0 | — | $0 | 30,432 | SEC↗ |
| CERU Cerulean Pharma Inc. | C Conversion deriv | 2014-04-15 | 2014-04-15 | 2,500,000 | — | $0 | 0 | SEC↗ |
| CERU Cerulean Pharma Inc. | C Conversion deriv | 2014-04-15 | 2014-04-15 | 441,528 | — | $0 | 0 | SEC↗ |
| CERU Cerulean Pharma Inc. | C Conversion | 2014-04-15 | 2014-04-15 | 468,263 | — | $0 | 1,266,484 | SEC↗ |
| CERU Cerulean Pharma Inc. | C Conversion | 2014-04-15 | 2014-04-15 | 184,314 | — | $0 | 798,221 | SEC↗ |
| CERU Cerulean Pharma Inc. | C Conversion | 2014-04-15 | 2014-04-15 | 355,307 | — | $0 | 613,907 | SEC↗ |
| CERU Cerulean Pharma Inc. | C Conversion | 2014-04-15 | 2014-04-15 | 181,399 | — | $0 | 258,600 | SEC↗ |
| CERU Cerulean Pharma Inc. | P Buy | 2014-04-15 | 2014-04-15 | 1,470,582 | $7.00 | $10.29M | 4,771,739 | SEC↗ |
| CERU Cerulean Pharma Inc. | C Conversion | 2014-04-15 | 2014-04-15 | 401,061 | — | $0 | 3,301,157 | SEC↗ |
| CERU Cerulean Pharma Inc. | C Conversion | 2014-04-15 | 2014-04-15 | 385,435 | — | $0 | 2,900,096 | SEC↗ |
| CERU Cerulean Pharma Inc. | C Conversion | 2014-04-15 | 2014-04-15 | 592,665 | — | $0 | 2,514,661 | SEC↗ |
| CERU Cerulean Pharma Inc. | C Conversion | 2014-04-15 | 2014-04-15 | 655,512 | — | $0 | 1,921,996 | SEC↗ |